251 related articles for article (PubMed ID: 9283213)
41. Poor outcome in disseminated intravascular coagulation or thrombotic thrombocytopenic purpura patients with severe vascular endothelial cell injuries.
Wada H; Mori Y; Shimura M; Hiyoyama K; Ioka M; Nakasaki T; Nishikawa M; Nakano M; Kumeda K; Kaneko T; Nakamura S; Shiku H
Am J Hematol; 1998 Jul; 58(3):189-94. PubMed ID: 9662269
[TBL] [Abstract][Full Text] [Related]
42. Diagnostic and Prognostic Value of TAT, PIC, TM, and t-PAIC in Malignant Tumor Patients With Venous Thrombosis.
Zhou K; Zhang J; Zheng ZR; Zhou YZ; Zhou X; Wang LD; Suo B; Jiang XF; Liu PJ; Wang DH
Clin Appl Thromb Hemost; 2020; 26():1076029620971041. PubMed ID: 33141604
[TBL] [Abstract][Full Text] [Related]
43. Differential diagnosis of localized and systemic amyloidosis based on coagulation and fibrinolysis parameters.
Suga N; Miura N; Kitagawa W; Morita H; Banno S; Imai H
Amyloid; 2012 Jun; 19(2):61-5. PubMed ID: 22417630
[TBL] [Abstract][Full Text] [Related]
44. Effects of recombinant human erythropoietin (EPOCH) on the coagulation and fibrinolytic systems and platelet function in pre-dialysis patients with chronic renal failure.
Kaizu K; Uriu K; Eto S
Nihon Jinzo Gakkai Shi; 1993 Aug; 35(8):989-97. PubMed ID: 8255011
[TBL] [Abstract][Full Text] [Related]
45. Coagulation and fibrinolysis in patients with chronic renal failure undergoing conservative treatment.
Tomura S; Nakamura Y; Deguchi F; Ando R; Chida Y; Marumo F
Thromb Res; 1991 Oct; 64(1):81-90. PubMed ID: 1776141
[TBL] [Abstract][Full Text] [Related]
46. Increased vascular endothelial cell markers in patients with disseminated intravascular coagulation.
Wada H; Minamikawa K; Wakita Y; Nakase T; Kaneko T; Ohiwa M; Tamaki S; Deguchi K; Shirakawa S; Hayashi T
Am J Hematol; 1993 Oct; 44(2):85-8. PubMed ID: 8266924
[TBL] [Abstract][Full Text] [Related]
47. Coagulation and fibrinolysis markers and risk of dementia. The Dutch Vascular Factors in Dementia Study.
Bots ML; Breteler MM; van Kooten F; Haverkate F; Meijer P; Koudstaal PJ; Grobbee DE; Kluft C
Haemostasis; 1998; 28(3-4):216-22. PubMed ID: 10420069
[TBL] [Abstract][Full Text] [Related]
48. Relationship between elevation in the plasma concentration of elastase-alpha 1 proteinase inhibitor complex (E-alpha 1 PI) and haemostatic parameters during haemodialysis.
Yamazaki M; Asakura H; Saito M; Jokaji H; Uotani C; Kumabashiri I; Morishita E; Aoshima K; Sato T; Tsugawa Y
Blood Coagul Fibrinolysis; 1995 Feb; 6(1):5-10. PubMed ID: 7795153
[TBL] [Abstract][Full Text] [Related]
49. Blood coagulation and fibrinolysis in eclamptic patients and their correlation with the clinical signs.
Halim A; Bhuiyan AB; Azim FA; Khatun S; Kanayama N; el Maradny E; Maehara K; Hiroshi K; Terao T
Gynecol Obstet Invest; 1995; 39(2):97-102. PubMed ID: 7772198
[TBL] [Abstract][Full Text] [Related]
50. Correlation between increased granulocyte elastase release and activation of blood coagulation in patients with lung cancer.
Gabazza E; Taguchi O; Yamakami T; Machishi M; Ibata H; Suzuki S
Cancer; 1993 Oct; 72(7):2134-40. PubMed ID: 7690680
[TBL] [Abstract][Full Text] [Related]
51. Coagulopathy associated with residual dissection after surgical treatment of type A aortic dissection.
Nakajima T; Kin H; Minagawa Y; Komoda K; Izumoto H; Kawazoe K
J Vasc Surg; 1997 Oct; 26(4):609-15. PubMed ID: 9357461
[TBL] [Abstract][Full Text] [Related]
52. Prethrombotic state due to hypercoagulability in patients with permanent transvenous pacemakers.
Ito T; Tanouchi J; Kato J; Nishino M; Iwai K; Tanahashi H; Hori M; Yamada Y; Kamada T
Angiology; 1997 Oct; 48(10):901-6. PubMed ID: 9342969
[TBL] [Abstract][Full Text] [Related]
53. Clinical significance of new coagulation and fibrinolytic markers in ischemic stroke patients.
Ono N; Koyama T; Suehiro A; Oku K; Fujikake K; Kakishita E
Stroke; 1991 Nov; 22(11):1369-73. PubMed ID: 1836283
[TBL] [Abstract][Full Text] [Related]
54. Relationship between intracoronary thrombolysis and fibrino-coagulation--special reference to TAT/PIC and FPA/PIC.
Uenomachi H; Sonoda M; Miyauchi T; Harubyu N; Nagata H; Miyahara K; Sanada J; Arima T
Jpn Circ J; 1996 Mar; 60(3):149-56. PubMed ID: 8741240
[TBL] [Abstract][Full Text] [Related]
55. Hemostasis, platelet function and serotonin in acute and chronic renal failure.
Malyszko J; Malyszko JS; Pawlak D; Pawlak K; Buczko W; Mysliwiec M
Thromb Res; 1996 Sep; 83(5):351-61. PubMed ID: 8873344
[TBL] [Abstract][Full Text] [Related]
56. The coagulation system is activated in idiopathic cardiomyopathy.
Yamamoto K; Ikeda U; Furuhashi K; Irokawa M; Nakayama T; Shimada K
J Am Coll Cardiol; 1995 Jun; 25(7):1634-40. PubMed ID: 7539015
[TBL] [Abstract][Full Text] [Related]
57. Level of antithrombin III, protein C, protein S and other selected parameters of coagulation and fibrinolysis in the blood of the patients with recurrent deep venous thrombosis.
Swiatkiewicz A; Jurkowski P; Kotschy M; Ciecierski M; Jawień A
Med Sci Monit; 2002 Apr; 8(4):CR263-8. PubMed ID: 11951068
[TBL] [Abstract][Full Text] [Related]
58. Abnormalities of blood coagulation and fibrinolysis in psoriasis.
Marongiu F; Sorano GG; Bibbò C; Pistis MP; Conti M; Mulas P; Balestrieri A; Biggio P
Dermatology; 1994; 189(1):32-7. PubMed ID: 7516205
[TBL] [Abstract][Full Text] [Related]
59. Interleukin-2 induces activation of coagulation and fibrinolysis: resemblance to the changes seen during experimental endotoxaemia.
Baars JW; de Boer JP; Wagstaff J; Roem D; Eerenberg-Belmer AJ; Nauta J; Pinedo HM; Hack CE
Br J Haematol; 1992 Oct; 82(2):295-301. PubMed ID: 1419810
[TBL] [Abstract][Full Text] [Related]
60. Plasma levels of the molecular markers of coagulation and fibrinolysis in patients with peripheral arterial disease.
Strano A; Hoppensteadt D; Walenga JM; Fareed J; Sabbá C; Berardi E; Allegra C; Carlizza A; Binaghi F; Fronteddu F; Del Guercio R; Del Guercio M; Pinto A; Alletto G; Nazzari M; Ferrari PA
Semin Thromb Hemost; 1996; 22 Suppl 1():35-40. PubMed ID: 8807727
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
